Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of carnosine supplementation on physical endurance: a placebo-controlled randomized clinical trial.

Journal of the International Society of Sports Nutrition·2026
Same author

Elucidating the Influence of Serum Concentration, Sex, and Particle Size on Iron Oxide Nanoparticle-Lipid Biocorona Formation.

Nanomaterials (Basel, Switzerland)·2026
Same author

Phospholipid Profiling Established by Structure-Rich Fragments for Molecular Species Level Shotgun Analysis.

Rapid communications in mass spectrometry : RCM·2026
Same author

Maternal ozone exposure and differential cardiometabolic outcomes in aging male and female offspring.

Toxicology and applied pharmacology·2025
Same author

Rotenone induced acute miRNA alterations in extracellular vesicles produce mitochondrial dysfunction and cell death.

NPJ Parkinson's disease·2025
Same author

Specialized Pro-Resolving Lipid Mediators Distinctly Modulate Silver Nanoparticle-Induced Pulmonary Inflammation in Healthy and Metabolic Syndrome Mouse Models.

Nanomaterials (Basel, Switzerland)·2024
Same journal

Engineering Functional Graphenic Materials for Bone Repair.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
Same journal

Breaking Through the Limits: Nanomedicine at the Service of New Drug Combinations to Tackle Pancreatic Cancer.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
Same journal

Advances in Engineered Virus-Like Particles for Applications in Nanomedicine.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
Same journal

Lipid- and Polymer-Based Nanoscale Delivery of Anti-Aging Phytochemicals.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
Same journal

Nano-Enabled Toxicity of Pharmaceutical Excipients.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
Same journal

Advances in Self-Assembly Artificial Chaperone for Protein Folding Regulation.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026
See all related articles

Related Experiment Video

Updated: May 19, 2026

Whole-Body Nanoparticle Aerosol Inhalation Exposures
10:11

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Published on: May 7, 2013

Changes in cardiopulmonary function induced by nanoparticles.

Erin E Mann1, Leslie C Thompson, Jonathan H Shannahan

  • 1Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC, USA.

Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|August 24, 2012
PubMed
Summary
This summary is machine-generated.

Nanoparticle exposure poses cardiovascular risks, potentially causing inflammation and oxidative stress. This review explores nanoparticle toxicity in the cardiovascular system and its health implications.

More Related Videos

Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects
06:57

Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects

Published on: February 12, 2021

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica
03:32

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica

Published on: April 12, 2019

Related Experiment Videos

Last Updated: May 19, 2026

Whole-Body Nanoparticle Aerosol Inhalation Exposures
10:11

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Published on: May 7, 2013

Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects
06:57

Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects

Published on: February 12, 2021

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica
03:32

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica

Published on: April 12, 2019

Area of Science:

  • Environmental Health
  • Toxicology
  • Cardiovascular Science

Background:

  • Nanoparticles (NP) exhibit unique properties, leading to widespread technological and biomedical applications.
  • Increased NP use has amplified human exposure, raising concerns about potential toxicity.
  • The cardiovascular (CV) system is increasingly recognized as a significant target for NP toxicity.

Purpose of the Study:

  • To review current knowledge on cardiovascular toxicity from NP exposure.
  • To elucidate mechanisms underlying NP-induced CV dysfunction.
  • To hypothesize health outcomes associated with NP-related CV effects.

Main Methods:

  • Literature review of studies investigating NP exposure and cardiovascular outcomes.
  • Analysis of proposed mechanisms including inflammation, oxidative stress, and direct cellular interactions.
  • Assessment of NP impact on vascular endothelial cells and cardiac function.

Main Results:

  • NP exposure can impair vascular endothelial cell integrity, affecting vascular tone and blood flow.
  • Cardiac effects include disrupted heart rate, electrical activity, and altered baroreceptor function.
  • Mechanisms involve inflammation, oxidative stress, autonomic dysregulation, and direct NP-cell interactions.

Conclusions:

  • NP toxicity can lead to serious cardiovascular events such as myocardial infarction, hypertension, arrhythmias, and thrombosis.
  • Understanding NP-CV interactions is crucial for assessing human health risks.
  • Further research is needed to fully characterize NP toxicity and mitigate adverse health effects.